Russia accelerates development of domestic anti-cancer drugs

Scientists at the Russian Granov Scientific Center for Radiology and Surgical Technologies have developed a new drug, which could be recommended for the use against severe forms of cancer, reports The Pharma Letter’s local correspondent.

According to developers, the use of the drug not only ensures the reduction in pain in patients, but also significantly improves their quality of life. They also noted this is a radiopharmaceutical drug, which is known under the name of "Actinium - PSMA".

Andrey Stanzhevsky, Granov Center’s deputy director for research, said in an interview with the Russian Kommersant business paper, until now, such drugs have not been available to patients in Russia, particularly in local anti-cancer clinics. As he also added there are foreign analogues, but they cannot be imported into Russia, due to logistics issues and lack of ability of transportation.